SCHEMBL25529698

SCHEMBL25529698

CC(C)Oc1ccc(C(C)(C)c2ccc(Oc3ccc(S(=O)(=O)c4ccc(C(C)(C)Oc5ccc(C(C)(C)c6ccc(O)cc6)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.44
GAA P10253 1/20 0.43
PKM P14618 1/20 0.43
MMP14 P50281 4/20 0.39
MMP2 P08253 3/20 0.39
MMP9 P14780 3/20 0.39
MMP3 P08254 2/20 0.39
ESR1 P03372 2/20 0.37
CYP3A4 P08684 2/20 0.37
ESR2 Q92731 2/20 0.37
AR P10275 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
HTR6 P50406 1/20 0.37
ESRRG P62508 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24178899 0.87 ELANE (0.47) ELANEGAAPKMMMP14MMP2
SCHEMBL16418026 0.84 ELANE (0.51) ELANEGAAPKMESR1ESR2
SCHEMBL20127284 0.83 ELANE (0.59) ELANEGAAPKMMMP14MMP2
SCHEMBL9679382 0.83 ELANE (0.59) ELANEGAAPKMMMP14MMP2
SCHEMBL22693012 0.83 ELANE (0.36) ELANEGAAPKMMMP14MMP2
SCHEMBL20169354 0.83 ELANE (0.50) ELANEGAAPKMMMP14MMP2
SCHEMBL24795065 0.82 MMP14 (0.45) ELANEGAAPKMMMP14MMP2
SCHEMBL19383057 0.82 MMP14 (0.45) ELANEGAAPKMMMP14MMP2
SCHEMBL24513216 0.81 HTT (0.51) MMP14MMP2MMP9MMP3HSD11B1
SCHEMBL13638342 0.81 ELANE (0.41) ELANEGAAPKMMMP14MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150930-A1 PHOTOCURABLE POLYMER COMPOSITIONS SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150930-A1 PHOTOCURABLE POLYMER COMPOSITIONS ALG3, HTR3D, LCP1 ELANE 2699/4885GAA 1970/4885PKM 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.